• How in five years, Del went from being anti-cannabis to co-founding and directing a psychedelic research non-profit organization.
• Why community-provided data about how psilocybin is actually being used, and the effects people are experiencing with it, is crucial for informing future research studies.
• How data points collected through such studies can lead to aligning the financial incentives of insurance companies to support plant-medicine empowered therapies.
* The Psychedelic Medicine Podcast has allowed the Psychedelic Medicine Association to post episodes as an educational resource, and in return the PMA is hosting the podcast show notes.
There was a problem reporting this post.
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.